Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/24/24 16:27 | 7/22/24 | ARTV | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | P.d | 100,000 | 12.00 | 0 | 8,333 | 827 | I | ||||||||||||||||
7/24/24 16:15 | 7/22/24 | ARTV | Health | BioPrd | Biological Products, (No Diag | 5Am Partners Vi, LLC | CA | T | P.d | 10,000 | 12.00 | 0 | 833 | 55 | 2,353 | I | |||||||||||||||
7/22/24 20:26 | 7/22/24 | ARTV | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund Iii, L.P. | CA | T | P.d | 5,000 | 12.00 | 0 | 417 | 27 | 1,937 | D | |||||||||||||||
7/22/24 20:25 | 7/22/24 | ARTV | Health | BioPrd | Biological Products, (No Diag | Gc Corp. | M5 | T | P.d | 25,000 | 12.00 | 0 | 2,083 | 84 | 4,567 | M | |||||||||||||||
7/22/24 20:22 | 7/22/24 | ARTV | Health | BioPrd | Biological Products, (No Diag | Huh Yong-Jun | CA | D | P.d | 25,000 | 12.00 | 0 | 2,083 | 84 | 4,567 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |